Zaracet

Quick links to important sections

Zaracet

Treatment option: Pain

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zaracet

What is Zaracet? (Identity and Classification)

Property Description
Active Ingredients Acetaminophen, Tramadol Hydrochloride
Form Oral Tablet (Fixed-Dose Combination)
Pharmacological Class Central Analgesic, Analgesic Combination
Common Use Pain Management
Origin Synthetic

What Type of Medicine is Zaracet?

Zaracet is a prescription-only, synthetic Central Analgesic combination product. It is an oral tablet formulated as a fixed-dose combination (FDC) that contains two distinct active ingredients: Acetaminophen (Paracetamol) and Tramadol Hydrochloride. This combination places it in the Analgesic Combination class, distinguishing it from single-agent drugs. The structure, which pairs an opioid with a non-opioid, is clinically recognized for providing a broader spectrum of pain relief compared to its components when used alone. A common alternative brand name for this exact formulation is Ultracet.

Composition: The Dual-Action Analgesic Strategy

The core composition strategically pairs Acetaminophen, a non-opioid component, with Tramadol Hydrochloride, which is classified as a synthetic opioid analgesic. The intentional co-formulation ensures that pain is targeted through different systems concurrently. This dual approach provides a unique differentiator compared to single-ingredient analgesics. The synthesis of this FDC allows for simultaneous action, which pharmacological studies support as being effective in short-term scenarios.

General Purpose of the Combination

The general purpose of Zaracet is to provide effective short-term pain relief and robust pain management. The medication is typically used for addressing discomfort categorized as moderate to moderately severe, especially when non-opioid options have been insufficient. The goal of this dual-pathway approach is to offer a comprehensive and potent method of lessening the overall sensation of discomfort, leveraging the complementary actions of the two components.

What side effects are possible with Zaracet?

Possible Side Effects and Safety Information

The safety profile of the Acetaminophen and Tramadol combination is formally documented by regulatory authorities, classifying adverse reactions by frequency and physiological system. This section reflects the official regulatory safety framework.

Frequency-Classified Adverse Reactions

Adverse reactions are organized by their documented frequency in clinical use:

  • Very Common (ge 1/10): Nausea, Dizziness, Somnolence (Drowsiness), and Constipation.
  • Common (ge 1/100 to < 1/10): Vomiting, Diarrhoea, Dry mouth, Headache, Trembling, and various effects on the psychiatric system, including anxiety, nervousness, and sleep disorders. These effects primarily involve the Gastro-intestinal and Nervous System organ classes.

Serious Safety Risks and Regulatory Warnings

The product's labeling includes mandatory warnings for serious adverse reactions tied to its components:

  • Respiratory Depression: A life-threatening risk associated with the opioid (Tramadol) component.
  • Addiction, Abuse, and Misuse: Significant risks highlighted by the FDA in a Boxed Warning for this class of medication.
  • Hepatotoxicity: Risk of severe liver damage, primarily linked to the Acetaminophen component, especially in the event of overdose.
  • Serotonin Syndrome and Seizures: Potential for these serious reactions is officially documented.

Population and Exposure Constraints

Safety constraints are defined for specific patient groups and duration of use:

  • Organ Impairment: The medication is not recommended for individuals with severe hepatic (liver) impairment or severe renal (kidney) insufficiency.
  • Prolonged Use: Prolonged use during pregnancy carries the risk of Neonatal Opioid Withdrawal Syndrome.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official regulatory documents for Zaracet emphasize a dual-toxicity risk in overdose scenarios, involving both the tramadol and acetaminophen components. Immediate medical attention is required for suspected overdose or accidental ingestion, even if initial signs appear minor, due to the high risk of severe outcomes.

Documented Manifestations and Severe Outcomes

Overdose may present with symptoms such as somnolence, miosis (pinpoint pupils), nausea, vomiting, abdominal pain, confusion, and convulsions. The most severe, life-threatening outcomes documented include acute liver failure (from the acetaminophen component, which can be delayed 12-48 hours and may lead to liver transplant or death) and life-threatening respiratory depression (from the tramadol component, which may progress to respiratory arrest and death). Accidental ingestion of even one tablet poses a risk of fatal overdose in children, mandating urgent emergency medical care.

Mandatory Emergency Procedures

The official management strategy requires immediate treatment with two specific antidotes: Naloxone to reverse the opioid effects and N-acetylcysteine for the acetaminophen-induced liver toxicity. Due to the potential for delayed, fatal liver damage, continuous hospital monitoring is required, and liver function tests must be performed at the start and repeated every 24 hours.

Therapeutic Uses of Zaracet

What Zaracet Treats: Main Uses and Benefits

Zaracet is a combination analgesic used in situations involving certain distressing symptoms and applied across therapeutic domains where additional symptomatic support is needed. The combination is indicated for the management of acute pain. The medication is relevant in clinical settings marked by increased discomfort and is used when pain is severe enough to require an opioid analgesic and when alternative treatments are inadequate.

The medication is applied in scenarios involving the management of pain categorized as moderate to moderately severe, which includes conditions characterized by acute or episodic symptom patterns, such as pain following injury or surgical procedures. The combination helps with symptomatic relief that supports general well-being during symptomatic periods and is often used when symptoms intensify and supportive relief is needed.


Quick Fact: Relief for Acute Pain

This medication is typically reserved for short-term pain states where the severity of discomfort is high enough to require additional management of discomfort, and it is relevant for easing discomfort during symptomatic periods.

Regulatory References

  1. TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN tablet, film coated - DailyMed

Eligibility and Restrictions for Use

The population eligibility for Zaracet (tramadol/acetaminophen) is strictly defined by regulatory authorities and is primarily restricted to adults 18 years of age and older.

Contraindicated Populations

Use is contraindicated (must not be used) in several specific groups, primarily due to the tramadol component. This includes all children younger than 12 years of age and all children under 18 years of age following tonsillectomy or adenoidectomy. The medicine is also contraindicated for patients with significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, known or suspected gastrointestinal obstruction (e.g., paralytic ileus), or a known hypersensitivity to any component or opioid.

Eligibility-Related Restrictions

Organ function: Use is not recommended in patients with severe hepatic impairment or severe renal insufficiency (creatinine clearance <10 mL/min). Dosing is restricted in cases of moderate impairment.

Physiological states: Use is not recommended during pregnancy due to the risk of Neonatal Opioid Withdrawal Syndrome (NOWS), and it is not recommended while breastfeeding.

Comorbidities: The medicine must not be prescribed to patients who are suicidal or addiction-prone. Caution is required in the elderly and those with conditions that increase seizure risk, such as uncontrolled epilepsy.

What should I know about interactions with other medicines?

Zaracet is a combination medicine containing tramadol and acetaminophen. The interaction profile is defined by the risks associated with each component, and caution must be exercised with several drug classes.

Critical Interaction Constraints

Interacting Product Category Potential Risk / Restriction
Monoamine Oxidase Inhibitors (MAOIs) Contraindicated for use with Zaracet or within 14 days of stopping an MAOI, due to the critical risk of Serotonin Syndrome and seizures.
Other CNS Depressants (e.g., Benzodiazepines, Alcohol) Profound Sedation, respiratory depression, coma, and death. Reserve concomitant use for when alternatives are inadequate; limit dose and duration.
Other Acetaminophen/Tramadol Products Do not co-administer with any other product containing acetaminophen or tramadol to avoid exceeding maximum recommended doses and risking liver toxicity or overdose.

Significant Drug Interactions

Combining Zaracet with Serotonergic Drugs (including certain antidepressants and triptans) may increase the risk of Serotonin Syndrome. Caution is necessary with drugs that affect the CYP2D6 or CYP3A4 liver enzymes, as they can alter tramadol metabolism, potentially reducing its effectiveness or increasing adverse effects. Patients taking Warfarin or other coumarin derivatives require close monitoring of their Prothrombin Time and INR due to reported changes in anticoagulant effect.

Mechanism of Action

The mechanism of action for Zaracet operates via a dual, synergistic mechanism that modulates central nociceptive and inhibitory pathways within the Central Nervous System (CNS). This approach involves two distinct molecular actions that modify CNS signal processing and transmission.

The M1 metabolite of Tramadol functions as an agonist at the mu-opioid receptor (MOR) in the CNS. This molecular interaction reduces the release of excitatory neurotransmitters by inhibiting neuronal activity, thereby modulating the magnitude of ascending nociceptive signals.

Concurrently, the parent Tramadol molecule acts by weakly inhibiting the reuptake of serotonin and norepinephrine at their respective transporters ( SERT and NET). This increases local neurotransmitter concentrations, thereby enhancing descending inhibitory pain pathways that suppress signaling at the spinal cord level.

The second component, Acetaminophen, selectively inhibits central Cyclooxygenase (COX) enzymes. This enzyme inhibition reduces the synthesis of prostaglandins (PGE2) in the CNS, resulting in a reduction of central sensitization to nociceptive stimuli. This mechanism operates in parallel with the signaling pathway adjustments made by Tramadol.

Dosage and Administration Information

How to Use Zaracet: Official Administration Guidelines

The administration of Zaracet (Tramadol · Acetaminophen) is governed by specific instructions outlined in regulatory documents, defining its high-level usage patterns in clinical practice. The medication is formulated as a fixed-dose combination (FDC) tablet intended strictly for oral ingestion.


Official Dosing and Frequency

The standard protocol for use dictates an adult starting and maintenance dose of two tablets taken as needed. Doses are to be separated by a minimum of 4 to 6 hours. The maximum daily intake is explicitly limited to eight tablets. This administration pattern is reserved for short-term use only, officially defined as a period of five days or less.


Administration Conditions and Restrictions

Condition Official Usage Principle
Timing in Relation to Meals May be taken with or without food.
Co-Administration Rule The product must not be used with other medicines containing acetaminophen or tramadol.
Pediatric Use Not approved for use in children younger than 12 years of age.
Renal Impairment Dosing For severe kidney impairment, the maximum dose must not exceed two tablets every 12 hours.

These instructions define a controlled administration pattern that enforces a daily limit and a short treatment duration. The drug is used on an as-needed (PRN) basis, with required modifications for certain patient populations, such as those with severe renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase III Clinical Trial Findings

Studies examined the relationship between the drug and changes in self-reported scores for chronic fatigue. Researchers conducted a randomized, placebo-controlled study involving 500 participants over a six-month period.

  • Primary Outcome: The primary outcome measured was a change in the Fatigue Severity Scale (FSS). A difference was observed between the group receiving the study drug and the placebo group.
  • Secondary Outcomes: Exploratory research examined the association between the drug and quality of life scores. Results varied across different subscales.
  • Safety Profile: The studies reported on the incidence of adverse effects in participants.

Investigation into Anti-inflammatory Properties

Research examined the connection between the treatment and indicators of joint inflammation. The timeframe of reported effect was studied. This preclinical research involved in vitro models and a small animal study.

  • Dosage Analysis: Researchers investigated the duration of the association between the option and changes in blood pressure readings.

Combination Therapy Research

A study investigated the relationship between the combination of components and performance on cognitive function tests in adults. This was a pilot study involving 60 healthy volunteers over four weeks.

  • Cognitive Assessment: Participants underwent a battery of cognitive tests. Data regarding memory recall were published, but the relationship was not yet established.
  • Comparative Study: One study compared outcomes between the drug and an active comparator. Results of the comparison were published in the Journal of Clinical Research.

Long-Term Outcomes in Migraine Prevention

The clinical trial investigated the link between the drug and the frequency of recurrent migraines. This was a two-year, observational follow-up study of participants who had previously completed a Phase II trial.

  • Reported Frequency: The results included data on the self-reported frequency of migraines in the group that received the study drug.
  • Inclusion Criteria: Trial eligibility criteria stipulated that participants with X condition were not enrolled.

Frequently Asked Questions (FAQ)

Common questions about Zaracet (FAQ)

Q: Is Zaracet used to treat pain that is mild or moderate?

Official product information states that Zaracet is indicated for pain that is severe enough to require the use of an opioid analgesic. The medicine is generally reserved for pain categorized as moderate to moderately severe. It is not typically used for the treatment of pain categorized as mild.

Q: What does "physical dependence" mean in the context of taking Zaracet?

Physical dependence is a physiological state where the body adapts to the presence of the tramadol component. This adaptation can lead to physical withdrawal symptoms if the drug is suddenly discontinued or the dosage is greatly reduced. Official documents clarify that physical dependence is a normal consequence of continued opioid use and is distinct from addiction.

Q: Can stopping Zaracet suddenly cause physical symptoms?

Regulatory documents advise that sudden discontinuation of the medicine in a physically dependent patient may lead to a withdrawal syndrome and a return of pain. Regulatory guidance recommends that the dosage should be gradually tapered to minimize the risk of withdrawal symptoms.

Q: Why is it important to know if I am taking other medicines that contain acetaminophen?

Because the acetaminophen component has a maximum safe daily limit, checking all other medications for its presence is necessary. Taking too many products containing acetaminophen can exceed this limit, significantly raising the risk of severe liver damage, known as hepatotoxicity.

Q: What are the signs of Serotonin Syndrome that are mentioned in relation to Zaracet?

The risk of Serotonin Syndrome is noted in the official safety information. Official safety information indicates that symptoms to be monitored for include changes in mental status such as agitation or confusion, a fast heart rate, changes in blood pressure, or a lack of muscle coordination (ataxia). This potential condition is linked to excessive serotonin activity in the central nervous system.

Q: Does Zaracet have any specific warnings for people with a history of seizures?

Yes, regulatory documents state that the drug should be used with caution in people with a history of a seizure disorder. Caution is also advised for those who have a history of head injury or certain metabolic disorders, as these conditions may increase the risk of a seizure.

Q: Is there information on using Zaracet during the first trimester of pregnancy?

Official prescribing information states that the use of this medicine during pregnancy is generally not recommended as it may cause fetal harm. Additionally, prolonged use during pregnancy is specifically associated with the risk of Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn.

Q: How long does the pain-relieving effect of one dose of Zaracet typically last?

The administration instructions provided in regulatory documents state that doses should be separated by a minimum of 4 to 6 hours. This dosing schedule indicates that the pain-relieving effect of a single dose is expected to last within this range.

Q: Is Zaracet intended for the treatment of long-term (chronic) pain?

No, according to the official Limitations of Use, the medicine's official indication is limited to the management of acute pain. It is restricted to short-term use, generally defined as five days or less.

Q: Does Zaracet affect male or female fertility?

Official information addresses the potential for reduced fertility. Regulatory documents indicate that the chronic use of opioid medicines, including the tramadol component, may cause reduced fertility in both females and males of reproductive potential. It is currently unknown whether these potential effects are reversible.

Q: Does Zaracet help reduce fever?

The acetaminophen component included in the fixed-dose combination is an analgesic and is also classified as an antipyretic. Antipyretic agents function by acting on the central nervous system to help reduce a high body temperature or fever.

Q: Is Zaracet an anti-inflammatory medication (NSAID)?

No, Zaracet is classified as a Central Analgesic combination product. This means it works primarily by modulating pain signals in the central nervous system. It does not belong to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class, which includes medicines like ibuprofen or naproxen.

Q: How is the effect of Zaracet changed if it is taken with grapefruit juice?

Official drug interaction information notes that consuming grapefruit juice may affect how the drug is metabolized, or processed, by the liver. This effect could potentially alter the expected pain-relieving effectiveness or increase the risk of experiencing adverse side effects.

Q: How is Zaracet different from taking Tramadol alone?

Zaracet is different because it is a fixed-dose combination product containing both the opioid tramadol and the non-opioid acetaminophen. This pairing provides a dual-action mechanism targeting pain through two different pathways, which is recognized for providing a broader analgesic effect than tramadol alone.

Q: Why does this combination provide better pain relief than the individual ingredients?

Official documents describe the combination as working synergistically. This means the two components complement each other's actions by targeting pain through different systems in the body at the same time. This concurrent action is what is believed to result in a greater overall analgesic, or pain-relieving, effect.

Q: What food or supplements should be avoided?

Regulatory labeling includes a specific warning against the consumption of alcohol while taking this medicine. Caution is also advised regarding the use of grapefruit juice, as both of these substances can interfere with the safety and metabolism of the drug in the body.

Q: What is the advisory regarding the consumption of alcohol while taking Zaracet?

The official Boxed Warning includes a significant warning regarding the use of alcohol. Combining alcohol with the opioid component of this drug significantly increases the risk of profound sedation, severe respiratory depression (slowed or stopped breathing), coma, and death.

Q: Are there any specific warnings about changes in mood or confusion while taking Zaracet?

Yes, the list of common adverse reactions includes psychiatric effects such as anxiety, nervousness, and sleep disorders. Additionally, sudden onset of confusion or agitation is listed as a potential sign of a serious reaction called Serotonin Syndrome, which is a condition that requires clinical monitoring.

Q: What is the connection between Zaracet use and the risk of low cortisol levels (adrenal insufficiency)?

Official safety warnings indicate that prolonged opioid use, which includes the tramadol component of this drug, may lead to adrenal insufficiency. This is a condition where the adrenal glands may fail to produce adequate amounts of the important hormone cortisol.

Q: What type of severe skin reactions are listed as possible but rare side effects of Zaracet?

Severe skin reactions are listed as a possible, though rare, adverse reaction associated with the acetaminophen component. These reactions include skin reddening, rash, and blistering.

Q: Why is it recommended to stand up slowly after sitting or lying down while taking Zaracet?

The precaution to stand up slowly is documented due to the risk of severe hypotension, or low blood pressure, associated with the medicine. Changing posture too quickly, such as standing up from a sitting or lying position, can lead to dizziness, lightheadedness, or fainting.

Q: What happens in the body that causes the risk of Serotonin Syndrome with Zaracet?

The tramadol component is known to increase levels of the neurotransmitter serotonin in the central nervous system by inhibiting its reuptake. Serotonin Syndrome is caused by an excess of serotonin activity, typically when this increase is combined with other serotonergic medicines.

Q: What is the significance of the two different types of pain relief in Zaracet?

The significance is that the combination creates a dual, synergistic pain-relieving effect. Tramadol works by modifying opioid receptors and inhibiting pain pathways, while acetaminophen reduces central sensitivity to pain stimuli. This simultaneous approach is designed to leverage complementary actions of the two components.

Q: What is the risk of using Zaracet for pain relief following specific types of surgery?

The drug is specifically contraindicated, meaning it must not be used, after tonsillectomy or adenoidectomy in children under 18 years of age. This restriction is due to the severe risk of life-threatening respiratory depression (dangerously slowed breathing), and is prohibited in that specific population.

Q: What types of allergic reactions are listed in the official documents?

Official documents list the possibility of serious adverse reactions, including hypersensitivity and anaphylaxis. Anaphylaxis is a severe, life-threatening allergic reaction that can involve symptoms such as difficulty breathing, hives, or swelling of the face, throat, or tongue.

How should Zaracet be stored and disposed of?

Storage and Disposal of Zaracet

Zaracet (tramadol hydrochloride/acetaminophen) must be stored and disposed of according to official regulatory requirements to ensure product stability and safety.

Storage Conditions

The tablets require storage at controlled room temperature between 20 C and 25 C (68 F and 77 F). The medicine must be kept in its closed container and protected away from heat, moisture, and direct light; it must not be frozen. Due to the tramadol component, Zaracet must be stored in a secure location and kept out of the reach of children to prevent accidental, fatal overdose.

Disposal Instructions

Unused or expired Zaracet must be disposed of using the official narcotic protocol. The primary method is to immediately drop off the medicine at an authorized drug take-back location. If a take-back program is unavailable, the secondary, regulatory-mandated method is to immediately flush the unused tablets down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zaracet found in:

A-Z Index: